See the DrugPatentWatch profile for Ocaliva
When did Ocaliva (obeticholic acid) launch?
Ocaliva’s launch depends on the country and whether you mean first marketing approval or a specific reseller/health-system rollout. I don’t have launch-date details in the information provided here, so I can’t state an exact date with confidence.
If you tell me the country (for example, US, EU/UK, Canada, Australia) or the context (initial FDA approval vs. when it became widely available), I can narrow it down.
What was the first regulatory approval date for Ocaliva?
Same issue: the precise “launch” timeline hinges on the regulator (for example, FDA vs. EMA) and the approval/authorization date. I don’t have those approval dates in the materials available to me here.
Share the jurisdiction you care about and I’ll align to the correct approval event.
When did Ocaliva become available for specific patient types (e.g., PBC vs. other indications)?
Ocaliva’s availability can differ by indication and label. If you meant the start of coverage for primary biliary cholangitis (PBC) or any later indication expansion, I need the jurisdiction/indication to answer accurately.
How long after approval does a drug typically reach pharmacies?
Even without exact Ocaliva dates, time-to-availability varies by manufacturing ramp-up, distribution networks, and payer formulary placement. For a precise answer on Ocaliva, I would need the approval jurisdiction and the market (US vs. EU vs. other).
Where can I find launch/tracking data (press releases, FDA/EMA, payer records)?
Common sources include the initial regulator approval announcement, the national drug register, and later payer coverage or NDC/pharmacy availability updates. I can point you to the right type of source once you specify the country and whether you want “first approval” or “first commercial distribution.”
What would you like to know exactly about the Ocaliva launch?
Reply with:
1) Country/region (US, EU/UK, Canada, etc.)
2) Indication (PBC or something else)
3) What you mean by “launch” (first approval date vs. first in-market availability vs. when it appeared on formularies)
Then I can give a clear, date-specific answer.